Stay updated with breaking news from Steven Tave. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
FDA has found the law's new dietary ingredient notification requirement would not adequate protect the public from CBD products that could pose safety concerns.
Despite a recent FDA enforcement action, bringing hangover products to market with provocative claims continues to be a siren call for the dietary supplement industry.
The Council for Responsible Nutrition has requested in a petition that FDA reverse its position that NAC cannot be lawfully marketed as a supplement.
FDA ‘not looking to throw out DSHEA’ An FDA official on Monday discussed the potential modernization of a 27-year-old law governing the regulation of dietary supplements. FDA in recent years has supported efforts to modernize the Dietary Supplement Health and Education Act of 1994 (DSHEA). But the agency “is not looking to throw out DSHEA and start fresh,” an FDA official said Monday during an event hosted by the American Herbal Products Association (AHPA). “Rather, we’re talking about building on the current framework,” said Cara Welch, Ph.D., acting director of FDA’s...
CRN: ‘This is not the final word on NAC’ While Amazon moves ahead with removing NAC-containing dietary supplements from its website, the FDA’s Office of Dietary Supplement Programs (ODSP) acknowledges that it is still reviewing the information around the ingredient. NAC (N-acetyl-L-cysteine) is a derivative of the amino acid L-cysteine and is a precursor of the cellular antioxidant glutathione. The ingredient was first approved as an inhaled mucolytic drug in 1963. At present it is used in emergency rooms as a treatment in cases of acetaminophen poisoning to ...